These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27557341)

  • 1. Thyroid Function and its Implications in Oxidative Stress Influencing the Pathogenesis of Osteoporosis in Adults with Down Syndrome: A Cohort Study.
    Villani ER; Onder G; Carfì A; Di Segni C; Raimondo S; Silvestrini A; Meucci E; Mancini A
    Horm Metab Res; 2016 Sep; 48(9):565-70. PubMed ID: 27557341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary disease.
    Mancini A; Corbo GM; Gaballo A; Raimondo S; Di Segni C; Gigliotti P; Silvestrini A; Valente S; Littarru GP; Pontecorvi A; Meucci E
    Exp Clin Endocrinol Diabetes; 2012 Nov; 120(10):623-8. PubMed ID: 23073919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Mineral Density Distribution Curves in Spanish Adults With Down Syndrome.
    Costa R; Gullón A; De Miguel R; de Asúa DR; Bautista A; García C; Suarez C; Castañeda S; Moldenhauer F
    J Clin Densitom; 2018; 21(4):493-500. PubMed ID: 29681439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of thyroid function status among postmenopausal women with and without osteoporosis.
    Acar B; Ozay AC; Ozay OE; Okyay E; Sisman AR; Ozaksoy D
    Int J Gynaecol Obstet; 2016 Jul; 134(1):53-7. PubMed ID: 27177516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune thyroiditis associated with mild "subclinical" hypothyroidism in adults with Down syndrome: a comparison of patients with and without manifestations of Alzheimer disease.
    Percy ME; Dalton AJ; Markovic VD; Crapper McLachlan DR; Gera E; Hummel JT; Rusk AC; Somerville MJ; Andrews DF; Walfish PG
    Am J Med Genet; 1990 Jun; 36(2):148-54. PubMed ID: 2142381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA; Nair V
    Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women.
    van Rijn LE; Pop VJ; Williams GR
    Eur J Endocrinol; 2014 Mar; 170(3):461-8. PubMed ID: 24336745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mass in young adults with Down syndrome.
    Guijarro M; Valero C; Paule B; Gonzalez-Macias J; Riancho JA
    J Intellect Disabil Res; 2008 Mar; 52(Pt 3):182-9. PubMed ID: 18261017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid dysfunction in patients with Down syndrome.
    Chen MH; Chen SJ; Su LY; Yang W
    Acta Paediatr Taiwan; 2007; 48(4):191-5. PubMed ID: 18265539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hypofunction in Down's syndrome: is it related to oxidative stress?
    Kanavin OJ; Aaseth J; Birketvedt GS
    Biol Trace Elem Res; 2000; 78(1-3):35-42. PubMed ID: 11314986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of congenital heart diseases and thyroid abnormalities in children with Down syndrome.
    Mıhçı E; Akçurin G; Eren E; Kardelen F; Akçurin S; Keser I; Ertuğ H
    Anadolu Kardiyol Derg; 2010 Oct; 10(5):440-5. PubMed ID: 20929702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of osteopenia/osteoporosis in adult scoliosis: does bone density affect surgical outcome?
    Yagi M; King AB; Boachie-Adjei O
    Spine (Phila Pa 1976); 2011 Sep; 36(20):1652-7. PubMed ID: 21304426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
    Heijckmann AC; Huijberts MS; Geusens P; de Vries J; Menheere PP; Wolffenbuttel BH
    Eur J Endocrinol; 2005 Jul; 153(1):23-9. PubMed ID: 15994742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density in adults with Down syndrome, intellectual disability, and nondisabled adults.
    Geijer JR; Stanish HI; Draheim CC; Dengel DR
    Am J Intellect Dev Disabil; 2014 Mar; 119(2):107-14. PubMed ID: 24679348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid dysfunction in patients with Down syndrome: Results from a multi-institutional registry study.
    Lavigne J; Sharr C; Elsharkawi I; Ozonoff A; Baumer N; Brasington C; Cannon S; Crissman B; Davidson E; Florez JC; Kishnani P; Lombardo A; Lyerly J; McDonough ME; Schwartz A; Berrier K; Sparks S; Stock-Guild K; Toler TL; Vellody K; Voelz L; Skotko BG
    Am J Med Genet A; 2017 Jun; 173(6):1539-1545. PubMed ID: 28332275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in adults with Down's syndrome.
    Angelopoulou N; Souftas V; Sakadamis A; Mandroukas K
    Eur Radiol; 1999; 9(4):648-51. PubMed ID: 10354878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density.
    Mazziotti G; Porcelli T; Patelli I; Vescovi PP; Giustina A
    Bone; 2010 Mar; 46(3):747-51. PubMed ID: 19892039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in adult growth hormone deficiency: different plasma antioxidant patterns in comparison with metabolic syndrome.
    Mancini A; Di Segni C; Bruno C; Olivieri G; Guidi F; Silvestrini A; Meucci E; Orlando P; Silvestri S; Tiano L; Pontecorvi A
    Endocrine; 2018 Jan; 59(1):130-136. PubMed ID: 29143180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.